ALGS logo

Aligos Therapeutics (ALGS) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$37.00 M
-$98.71 M-72.74%

December 31, 2024


Summary


Performance

ALGS Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALGSbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$37.00 M
+$1.67 M+4.72%

December 31, 2024


Summary


Performance

ALGS Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherALGSbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

ALGS Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-72.7%+4.7%
3 y3 years-80.2%-53.0%
5 y5 years-46.8%-53.0%

ALGS Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-80.2%at low-80.2%+53.2%
5 y5-year-83.2%at low-84.6%+53.2%
alltimeall time-83.2%+53.9%-84.6%+53.2%

Aligos Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
$37.00 M(-72.7%)
$37.00 M(+4.7%)
Sep 2024
-
$35.33 M(-21.6%)
Jun 2024
-
$45.08 M(+86.7%)
Mar 2024
-
$24.15 M(-82.2%)
Dec 2023
$135.70 M(+66.8%)
$135.70 M(+92.7%)
Sep 2023
-
$70.43 M(-22.5%)
Jun 2023
-
$90.83 M(+15.5%)
Mar 2023
-
$78.67 M(-3.3%)
Dec 2022
$81.35 M
$81.35 M(-5.9%)
Sep 2022
-
$86.44 M(+21.5%)
DateAnnualQuarterly
Jun 2022
-
$71.17 M(-31.9%)
Mar 2022
-
$104.56 M(-44.0%)
Dec 2021
$186.82 M(-15.2%)
$186.82 M(-22.1%)
Sep 2021
-
$239.73 M(+27.8%)
Jun 2021
-
$187.65 M(-6.3%)
Mar 2021
-
$200.36 M(-9.1%)
Dec 2020
$220.38 M(+216.8%)
$220.38 M(+592.7%)
Sep 2020
-
$31.82 M(-49.9%)
Jun 2020
-
$63.45 M(-8.8%)
Dec 2019
$69.56 M(+189.4%)
$69.56 M
Dec 2018
$24.04 M
-

FAQ

  • What is Aligos Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Aligos Therapeutics?
  • What is Aligos Therapeutics annual cash & cash equivalents year-on-year change?
  • What is Aligos Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Aligos Therapeutics?
  • What is Aligos Therapeutics quarterly cash and cash equivalents year-on-year change?

What is Aligos Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of ALGS is $37.00 M

What is the all time high annual cash & cash equivalents for Aligos Therapeutics?

Aligos Therapeutics all-time high annual cash & cash equivalents is $220.38 M

What is Aligos Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, ALGS annual cash & cash equivalents has changed by -$98.71 M (-72.74%)

What is Aligos Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of ALGS is $37.00 M

What is the all time high quarterly cash and cash equivalents for Aligos Therapeutics?

Aligos Therapeutics all-time high quarterly cash and cash equivalents is $239.73 M

What is Aligos Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, ALGS quarterly cash and cash equivalents has changed by +$1.67 M (+4.72%)